Definitive Contract 75A50122C00022

Award Date 4/4/22
Potential Completion Date 1/31/24
Potential Value $726K
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
San Francisco, CA 94143, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Department of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, awarded a $508,865.04 firm-fixed price contract to the J. David Gladstone Institutes, a non-profit biomedical research organization in San Francisco, California. The contract is for research and development to multiplex CRISPR-Cas13A technology for an at-home viral diagnostic, in support of the agency's efforts to enable home-based diagnostics for SARS-CoV-2 acute infection. This...
The Centers for Disease Control and Prevention (CDC) awarded The Regents of the University of California, San Francisco (UCSF) a $6,115,923.22 definitive cost-no-fee contract for the "National History of SARS-CoV-2 Infection" project. The contract has a completion date of May 31, 2024. UCSF, a public academic medical center and research university, has a long history of conducting biomedical research, clinical trials, and providing healthcare and technical services under federal...
This federal contract award is for sequencing services for two libraries, awarded by the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases to The Regents of the University of California, San Francisco (UCSF). The contract has a firm fixed price of $15,876.00 and was awarded on July 12, 2018 with a completion date of July 11, 2019. There was no set-aside designation. UCSF is a public academic medical center and research...
This is a $152,588.29 firm fixed-price purchase order contract awarded by the Office of Logistics and Acquisition Operations (part of the U.S. Department of Health and Human Services) to the University of California, San Francisco (UCSF). The contract is not set aside for any specific category. UCSF is a prominent academic medical center and research institution with a strong track record of securing federal contracts and grants, particularly from agencies like the National Institutes of Health,...
This definitive contract was awarded by the National Institutes of Health National Cancer Institute to The Regents of the University of California, San Francisco for $856,497.00. Under the contract, the University will provide digital health solutions to support COVID-19 response efforts, including the COVIDSEEKER and COVID-19 Citizen Science programs. The work will be performed in San Francisco, California over a one year period ending in September 2021. The contract type is firm fixed price....
This is a $653,563.97 definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to The Regents of the University of California, San Francisco (UCSF) on May 15, 2021. The contract is for FY21 BAA TOPIC 8 - UCSF 8.2 and does not have a set-aside designation. UCSF, a public academic medical center and research university, will be providing research services to the CDC through this contract, which has a performance period ending on May 14, 2023. UCSF has a history of...
The University of California, Los Angeles (UCLA), through its Office of Research Administration, has been awarded a $749,000.00 firm fixed-price contract by the U.S. Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response. The contract involves research and development for scalable sequencing approaches to detect novel pathogens, with a focus on next-generation sequencing-based diagnostic tools for respiratory RNA virus pathogens. The contract has...
This definitive contract from the Department of Health and Human Services Centers for Disease Control and Prevention (HHS-CDC) awards $1,595,336 to The Regents of the University of California, San Francisco (UCSF) as the prime contractor to conduct a clinical study examining the effects of N95 respirator extended use and reuse in healthcare settings. Major subcontractors include The Johns Hopkins University, Emory University, the University of Wisconsin-Madison, and the University of...
This is a $52,239,640.00 definitive contract awarded to Visby Medical, Inc. by the U.S. Department of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response. The contract is for the delivery of a rapid, accurate, point-of-care disposable influenza and SARS-CoV-2 molecular diagnostic test. This award is not set aside for any particular business classification. The contract has an ultimate completion date of March 31, 2026. The original solicitation was issued...
This is a $630,976 firm fixed-price definitive contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian federal agency, to Karius, Inc., a life sciences company headquartered in Redwood City, California. The contract is for research and development of metagenomic sequencing of microbial cell-free DNA and RNA for comprehensive pathogen detection. Karius, Inc. is a specialized provider of advanced molecular diagnostic testing and next-generation...

This is a $726,102 firm fixed-price contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR) to The Regents of the University of California, San Francisco (UCSF) for clinical validation of a next-generation sequencing (NGS)-based diagnostic test for respiratory viral pathogens, including SARS-CoV-2. The contract is funded through ASPR's Division of Research, Innovation, and Ventures (DRIVe) and was competitively awarded without a set-aside. It includes two main tasks: 1) developing a regulatory strategy and submitting a Breakthrough Device Designation request to the FDA, and 2) validating the NGS test in a CAP/CLIA laboratory. UCSF has subcontracted a portion of the work to Mriglobal, a not-for-profit research organization, to support the regulatory and validation activities. The contract has an ultimate completion date of January 31, 2024.

Generated 7/1/25, 8:59 AM